4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-23-016935
SVP, Chief Legal Officer gave up 8,164 shares (to pay taxes)
- SVP, Chief Legal Officer acquired 22,645 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Daly Jason B. SVP, Chief Legal Officer | 2023-03-03 | Option exercise | +22,645 | 22,645 | D | ||
| Daly Jason B. SVP, Chief Legal Officer | 2023-03-03 | Shares withheld for taxes | −8,164 | $1.92 | $15,675 | 14,481 | D |
| Derivatives | |||||||
| Daly Jason B. SVP, Chief Legal Officer | 2023-03-03 | Option exercise · Restricted Stock Units | −22,645 | 67,935 | D | ||
| Daly Jason B. SVP, Chief Legal Officer | 2023-03-03 | Grant or award · Restricted Stock Units | +152,905 | 152,905 | D | ||
| Daly Jason B. SVP, Chief Legal Officer | 2023-03-03 | Grant or award · Performance-Based Restricted Stock Units | +305,810 | 305,810 | D | ||
Loading xslF345X03/doc4.xml…